One of the limitations of these studies is that they did not differentiate between the infectious-onset vs noninfectious-onset of ME/CFS, as did Steiner et al
doi: 10.1111/jfbc.13810 140 LiuSYaoSYangHLiuSWangY
Liu Y, Yang Y, Jiang L, Xu H, Wei J
The trial enrolled only people with overweight or obesity and no obesity-related illnesses
Most people notice reduced appetite within the first two to four weeks
PlexusDx Tirzepatide Options and Personalized Protocol Design PlexusDx offers Compounded Tirzepatide Injection at $289/mo month-to-month, or from $249/mo on the 6-month plan (licensed 503A compounding pharmacy), Oral Tirzepatide at $349/mo (or $279/mo on the 6-month plan), and GLP-Squared Injection (dual semaglutide and tirzepatide) at $289/mo (or $249/mo on the 3-month plan), with the pricing guarantee that your dose may increase without increasing your monthly cost